Green synthesis of controlled size gold and silver nanoparticles using antioxidant as capping and reducing agent

Here silver (GA-AgNPs) and gold nanoparticles (GA-AuNPs) were synthesized by an ecofriendly method using antioxidant, gallic acid (GA) simultaneously as capping and reducing agent. Their size ranged between 15 nm and 80 nm, which was controlled or dependent on the feeding ratio of GA. There was a li...

Full description

Saved in:
Bibliographic Details
Published inColloid and interface science communications Vol. 39; p. 100322
Main Authors Khan, Musammir, Ahmad, Fawad, Koivisto, Janne T., Kellomäki, Minna
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Here silver (GA-AgNPs) and gold nanoparticles (GA-AuNPs) were synthesized by an ecofriendly method using antioxidant, gallic acid (GA) simultaneously as capping and reducing agent. Their size ranged between 15 nm and 80 nm, which was controlled or dependent on the feeding ratio of GA. There was a linear relationship between the particle sizes versus the GA content. Moreover, they indicated a negative zeta potential value, which was decreased from −33 mV to −40 mV for AgNPs and from −36 mV to −42 mV for AuNPs after the addition of GA . In a typical PEGylation reaction of them, resulted into a large increase in the particle size as well as zeta potential value. The cytotoxicity assay against human fibroblast cell line (WI-38) for 24 h and 3-days showed that they were completely safe toward these cells. Therefore, these engineered NPs could be considered promising supplementary targeting materials in future. [Display omitted] •Green synthesis of silver (Ag) and gold (Au) Nanoparticles (PNPs).•Using natural antioxidant gallic acid (GA) as capping and reducing agent.•Systematic control of particle size and surface properties as a function of GA concentration.•Performing the surface modification of GA-NPs via PEGylation.•Biocompatible GA capped NPs (GA-NPs) as future biomedical targeting materials.
ISSN:2215-0382
2215-0382
DOI:10.1016/j.colcom.2020.100322